Related Experiment Video
Updated: Nov 12, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
[Correlation between early inflammation indicators and the severity of coronavirus disease 2019]
Yong Li1, Suhan Lin1, Yueying Zhou2
1Department of Emergency, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Insights
Early inflammation indicators like C-reactive protein (CRP) and the Multilobar Infiltration, Hypo-lymphocytosis, Bacterial Coinfection, Smoking History, Hypertension, and Age (MuLBSTA) score can predict severe coronavirus disease 2019 (COVID-19). These markers show potential for identifying high-risk patients.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) severity varies significantly among patients.
- Identifying early indicators of disease progression is crucial for timely intervention.
- Inflammation plays a key role in the pathogenesis of severe COVID-19.
Purpose of the Study:
- To investigate the association between early inflammation markers and COVID-19 severity.
- To evaluate the predictive value of these markers for progression to severe or critical illness.
Main Methods:
- Retrospective study of 140 COVID-19 patients.
- Collected demographic data, chest CT scans, and initial laboratory parameters.
- Utilized logistic regression and ROC curve analysis to assess inflammation indicators (CRP, NLR, MuLBSTA score) and disease severity.
Main Results:
- Significant differences observed in age, comorbidities, C-reactive protein (CRP), lymphocyte count, neutrophil/lymphocyte ratio (NLR), and MuLBSTA score between mild/common and severe/critical groups.
- Multivariate analysis identified CRP and MuLBSTA score as independent risk factors for severe COVID-19.
- ROC analysis demonstrated good predictive ability for CRP (AUC=0.818) and MuLBSTA score (AUC=0.818) for severe/critical cases.
Conclusions:
- C-reactive protein (CRP) and the Multilobar Infiltration, Hypo-lymphocytosis, Bacterial Coinfection, Smoking History, Hypertension, and Age (MuLBSTA) score are significantly related to COVID-19 severity.
- These markers possess independent predictive value for identifying patients at risk of developing severe or critical illness.
Objective:
To explore the correlation between early inflammation indicators and the severity of coronavirus disease 2019 (COVID-19).
Methods:
A retrospective study was conducted. Patients with COVID-19 admitted to Wenzhou Central Hospital from January 17 to February 14, 2020 were enrolled. The general information, chest CT before admission, the first laboratory parameters and chest CT within 24 hours after admission were collected. Patients were followed up for 30 days after the first onset of dyspnea or pulmonary imaging showed that the lesions progressed more than 50% within 24 to 48 hours (according to the criteria for severe cases) as the study endpoint. According to the endpoint, the patients were divided into two groups: mild type/common type group and severe/critical group, and the differences in general information and inflammation index of the two groups were compared. Logistic regression was used to analyze the inflammation index and the severity of COVID-19. Receiver operating characteristic (ROC) curve was draw to evaluate the predictive value of early inflammation indicators for severe/critical in patients with COVID-19.
Results:
A total of 140 patients with COVID-19 were included, 74 males and 66 females; the average age was (45±14) years old; 6 cases (4.3%) of mild type, 107 cases (76.4%) of common type, and 22 cases (15.7%) of severe type, 5 cases (3.6%) were critical. There were significantly differences in ages (years old: 43±13 vs. 57±13), the proportion of patients with one chronic disease (17.7% vs. 55.6%), C-reactive protein [CRP (mg/L): 7.3 (2.3, 21.0) vs. 40.1 (18.8, 62.6)], lymphocyte count [LYM (×109/L): 1.3 (1.0, 1.8) vs. 0.8 (0.7, 1.1)], the neutrophil/lymphocyte ratio [NLR: 2.1 (1.6, 3.0) vs. 3.1 (2.2, 8.8)] and multilobularinltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age [MuLBSTA score: 5.0 (3.0, 5.0) vs. 5.0 (5.0, 7.0)] between mild/common group and severe/critical group (all P < 0.05). Univariate Logistic regression analysis showed that CRP, NLR, MuLBSTA score, age, and whether chronic diseases were associated with the severity of COVID-19 [odds ratio (OR) and 95% confidence interval (95%CI) were 1.037 (1.020-1.055), 1.374 (1.123-1.680), 1.574 (1.296-1.911), 1.082 (1.042-1.125), 6.393 (2.551-16.023), respectively, all P < 0.01]. Further multivariate Logistic regression analysis showed that CRP and MuLBSTA score were risk factors for the development of COVID-19 to severe/critical cases [OR and 95%CI were 1.024 (1.002-1.048) and 1.321 (1.027-1.699) respectively, both P < 0.05]. ROC curve analysis showed that the area under the curve for CRP and MuLBSTA score to predict severe/critical cases were both 0.818, and the best cut-off points were 27.4 mg/L and 6.0 points, respectively.
Conclusions:
CRP and MuLBSTA score are related to the severity of COVID-19, and may have good independent predictive ability for the development of severe/critical illness.
More Related Videos
Related Concept Videos
Correlations
Inflammation
Myocarditis II: Clinical Features and Diagnostic Tests
Correlation
Two variables, for example, a and b, are said to be positively correlated if both variables move in the same direction. In other words, a positive correlation exists between two variables, a and b, if:
Inflammatory Response I: Vascular and Cellular
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

